About Us

Company Profile

Management Team

Investors

Scientific Advisor

Contact Us

Our Approach

Why ADC？

Duality Novel Platforms

Pipeline
Media

Corporate News

Industry Dynamics

Partnership

Collaboration Model

Collaboration Cases

Careers

Corporate Culture

Job Opportunities

MEDIA
MEDIA
Corporate News
Industry Dynamics
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA)
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA)
2023-01-29
Strategic Collaboration｜Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
Strategic Collaboration｜Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
2023-01-05
Duality Biologics Completed $90 Million Series B Financing
Duality Biologics Completed $90 Million Series B Financing
2021-05-20
Strategic Collaboration｜Duality Biologics and Harbour BioMed reached a strategic collaboration agreement
Strategic Collaboration｜Duality Biologics and Harbour BioMed reached a strategic collaboration agreement
2022-01-24
Duality Biologics is awarded as 2020 SIPAC (Suzhou Industrial Park) Key Leading Talent Programme
Duality Biologics is awarded as 2020 SIPAC (Suzhou Industrial Park) Key Leading Talent Programme
2021-05-06
Strategic Collaboration｜Duality Biologics and Sinotau Pharmaceuticals reached a strategic collaboration agreement
Strategic Collaboration｜Duality Biologics and Sinotau Pharmaceuticals reached a strategic collaboration agreement
2021-12-20
Our First Team Building Activties
Our First Team Building Activties
2021-09-01